BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27132993)

  • 1. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
    Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
    Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial role in oxaliplatin-induced neuropathic pain.
    Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C
    Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement.
    Di Cesare Mannelli L; Cinci L; Micheli L; Zanardelli M; Pacini A; McIntosh JM; Ghelardini C
    Pain; 2014 Oct; 155(10):1986-95. PubMed ID: 25008370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.
    Di Cesare Mannelli L; Pacini A; Matera C; Zanardelli M; Mello T; De Amici M; Dallanoce C; Ghelardini C
    Neuropharmacology; 2014 Apr; 79():37-48. PubMed ID: 24225197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain.
    Di Cesare Mannelli L; Pacini A; Bonaccini L; Zanardelli M; Mello T; Ghelardini C
    J Pain; 2013 Dec; 14(12):1585-600. PubMed ID: 24135431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
    Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
    Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
    BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
    Wala EP; Crooks PA; McIntosh JM; Holtman JR
    Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.
    Yoon SY; Robinson CR; Zhang H; Dougherty PM
    J Pain; 2013 Feb; 14(2):205-14. PubMed ID: 23374942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.
    Sakurai M; Egashira N; Kawashiri T; Yano T; Ikesue H; Oishi R
    Pain; 2009 Dec; 147(1-3):165-74. PubMed ID: 19782472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
    Joseph EK; Chen X; Bogen O; Levine JD
    J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation.
    Di Cesare Mannelli L; Tenci B; Micheli L; Vona A; Corti F; Zanardelli M; Lapucci A; Clemente AM; Failli P; Ghelardini C
    Neuropharmacology; 2018 Mar; 131():166-175. PubMed ID: 29241656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model.
    Wang H; Li X; Qiao Y; Wang M; Wang W; McIntosh JM; Zhangsun D; Luo S
    Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38276651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats.
    Huynh PN; Giuvelis D; Christensen S; Tucker KL; McIntosh JM
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
    Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
    J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats.
    Hatashita S; Sekiguchi M; Kobayashi H; Konno S; Kikuchi S
    Spine (Phila Pa 1976); 2008 May; 33(12):1344-51. PubMed ID: 18496347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy.
    Dyachenko IA; Palikova YA; Palikov VA; Korolkova YV; Kazakov VA; Egorova NS; Garifulina AI; Utkin YN; Tsetlin VI; Kryukova EV
    Biochimie; 2022 Mar; 194():127-136. PubMed ID: 34979156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence.
    Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
    Pain; 2011 Jan; 152(1):170-181. PubMed ID: 21071147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats.
    Ferrier J; Bayet-Robert M; Pereira B; Daulhac L; Eschalier A; Pezet D; Moulinoux JP; Balayssac D
    PLoS One; 2013; 8(10):e77828. PubMed ID: 24204988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.